US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

0.7525

-0.0225-2.90%

Post-market: 0.77480.0223+2.96%19:25 EDT

Volume:79.54K

Turnover:60.65K

Market Cap:14.72M

PE:-0.28

High:0.7899

Open:0.7849

Low:0.7412

Close:0.7750

Loading ...

Overview Company News Filings

Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares

Metavia Inc. Faces Nasdaq Delisting Risk Due to Sub-$1 Stock Price

Metavia Inc. Unveils Presentation on Innovative Cardiometabolic Therapies Targeting Obesity and MASH

Dong-A ST Co., Ltd Acquires Common Shares of Metavia Inc

MetaVia Is Maintained at Buy by Maxim Group

MetaVia price target lowered to $3 from $6 at Maxim

Maxim Group Sticks to Its Buy Rating for MetaVia (MTVA)

MetaVia Inc reports results for the quarter ended March 31 - Earnings Summary

MetaVia Q1 EPS $(0.36) Beats $(0.51) Estimate

Metavia Inc: Qtrly Loss per Share $0.36

THOMSON REUTERS

Metavia Inc Q1 Shr View $-0.60 -- Lseg Ibes Data

THOMSON REUTERS

Metavia Inc. Reports Q1 2025 Results: Net Loss Narrows to $3.7 Million, EPS Improves to $0.36 per Share

Metavia Reports First Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS

MetaVia Inc. Announces $10 Million At-The-Market Private Placement to Fund Clinical Development

BRIEF-Metavia Announces $10 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Metavia Announces $10.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

Metavia Inc - Proceeds to Fund Da-1726 Clinical Development for Obesity

THOMSON REUTERS

Metavia Inc - Offering Includes Purchase of 9,479,345 Shares at $0.71 Each

THOMSON REUTERS

MetaVia announces data from DA-1241 trial at EASL

MetaVia Inc expected to post a loss of 60 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MTVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":0.7525,"timestamp":1749672000000,"preClose":0.775,"halted":0,"volume":79539,"hourTrading":{"tag":"盘后","latestPrice":0.7748,"preClose":0.7525,"latestTime":"19:25 EDT","volume":2650,"amount":1988.7222,"timestamp":1749684307812},"delay":0,"floatShares":13245900,"shares":19564214,"eps":-2.717151,"marketStatus":"Closed","change":-0.0225,"latestTime":"06-11 16:00:00 EDT","open":0.7849,"high":0.789899,"low":0.7412,"amount":60647.1591987,"amplitude":0.062837,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.717151,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749715200000},"marketStatusCode":5,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.775,"postHourTrading":{"tag":"盘后","latestPrice":0.7748,"preClose":0.7525,"latestTime":"19:25 EDT","volume":2650,"amount":1988.7222,"timestamp":1749684307812},"volumeRatio":0.560387},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":13245900,"roa":"-110.71%","roe":"-339.64%","lyrEps":-3.556986,"volumeRatio":0.560387,"shares":19564214,"dividePrice":0,"high":0.789899,"amplitude":0.062837,"preClose":0.775,"low":0.7412,"week52Low":0.6326,"pbRate":"3.36","week52High":5.3,"institutionHeld":0,"latestPrice":0.7525,"eps":-2.717151,"divideRate":0,"volume":79539,"delay":0,"ttmEps":-2.717151,"open":0.7849,"prevYearClose":2.03,"prevWeekClose":0.6922,"prevMonthClose":0.6502,"prevQuarterClose":1.54,"fiveDayClose":0.6869,"twentyDayClose":0.65,"sixtyDayClose":1.5901},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541096607","title":"Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2541096607","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541096607?lang=en_us&edition=fundamental","pubTime":"2025-06-05 04:01","pubTimestamp":1749067306,"startTime":"0","endTime":"0","summary":"Marshall H. Woodworth, the Chief Financial Officer of Metavia Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9kDcxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares","news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2539038842","title":"Metavia Inc. Faces Nasdaq Delisting Risk Due to Sub-$1 Stock Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2539038842","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539038842?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:06","pubTimestamp":1748639204,"startTime":"0","endTime":"0","summary":"Metavia Inc. has announced that it received a notice from the Nasdaq Stock Market LLC on May 29, 2025, indicating that the company's common stock has not met the minimum bid price requirement for continued listing on the Nasdaq Capital Market. For the past 30 consecutive business days, Metavia's stock has closed below $1.00 per share, falling short of the requirement outlined in Nasdaq Marketplace Rule 5550. The company has until November 25, 2025, to regain compliance, either by achieving a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days or by other measures such as a reverse stock split. If compliance is not achieved, Metavia may pursue additional time but could face delisting from Nasdaq if the issue remains unresolved. The company is actively monitoring its stock price and exploring options to address the deficiency.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDLRnHTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2537935332","title":"Metavia Inc. Unveils Presentation on Innovative Cardiometabolic Therapies Targeting Obesity and MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935332","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935332?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:08","pubTimestamp":1747832923,"startTime":"0","endTime":"0","summary":"MetaVia Inc., a clinical-stage biotech company focused on cardiometabolic diseases, recently presented updates on its pipeline of next-generation therapeutics targeting obesity and MASH. The company's investigational drug, DA-1726, a novel GLP1R/GCGR dual agonist, is currently in Phase 1 trials and has shown promising results with significant weight loss and reductions in fasted glucose levels. Additionally, DA-1241, targeting MASH, has met its Phase 2a primary endpoint, demonstrating direct hepatic effects and a strong safety profile. MetaVia continues to explore further studies and regulatory interactions for these treatments. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL2lLtmb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2537623689","title":"Dong-A ST Co., Ltd Acquires Common Shares of Metavia Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537623689","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537623689?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:17","pubTimestamp":1747772238,"startTime":"0","endTime":"0","summary":"Dong-A ST Co., Ltd, a beneficial owner, reported an acquisition of common shares of Metavia Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL8h4Ngl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2536406636","title":"MetaVia Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2536406636","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536406636?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:09","pubTimestamp":1747670940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MTVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 12:09 ET (16:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0},{"id":"2536682349","title":"MetaVia price target lowered to $3 from $6 at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2536682349","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536682349?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:50","pubTimestamp":1747659011,"startTime":"0","endTime":"0","summary":"Maxim analyst Jason McCarthy lowered the firm’s price target on MetaVia (MTVA) to $3 from $6 and keeps a Buy rating on the shares. The firm cites t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-price-target-lowered-to-3-from-6-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-price-target-lowered-to-3-from-6-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2536586601","title":"Maxim Group Sticks to Its Buy Rating for MetaVia (MTVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536586601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536586601?lang=en_us&edition=fundamental","pubTime":"2025-05-17 21:55","pubTimestamp":1747490121,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy maintained a Buy rating on MetaVia (MTVA – Research Report) yesterday. The company’s shares closed yesterday at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-metavia-mtva?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-metavia-mtva?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA"],"gpt_icon":0},{"id":"2535557883","title":"MetaVia Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535557883","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535557883?lang=en_us&edition=fundamental","pubTime":"2025-05-15 05:07","pubTimestamp":1747256864,"startTime":"0","endTime":"0","summary":"MetaVia Inc reports results for the quarter ended March 31 - Earnings SummaryMetaVia Inc MTVA.OQ reported a quarterly adjusted loss of 36 cents per share for the quarter ended March 31, higher than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL8N3RM2TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0},{"id":"2535000798","title":"MetaVia Q1 EPS $(0.36) Beats $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535000798","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535000798?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:38","pubTimestamp":1747255134,"startTime":"0","endTime":"0","summary":"MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.51) by 29.41 percent. This is a 72.73 percent increase over losses of $(1.32) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45421823/metavia-q1-eps-0-36-beats-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0},{"id":"2535160007","title":"Metavia Inc: Qtrly Loss per Share $0.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2535160007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535160007?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:18","pubTimestamp":1747253922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM2YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2535071980","title":"Metavia Inc  Q1 Shr View $-0.60 -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2535071980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535071980?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:18","pubTimestamp":1747253922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM2YS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2535002074","title":"Metavia Inc. Reports Q1 2025 Results: Net Loss Narrows to $3.7 Million, EPS Improves to $0.36 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2535002074","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535002074?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:07","pubTimestamp":1747253267,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL13dCC7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0},{"id":"2535002258","title":"Metavia Reports First Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535002258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535002258?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:05","pubTimestamp":1747253109,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA6C5VTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2535244710","title":"MetaVia Inc. Announces $10 Million At-The-Market Private Placement to Fund Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2535244710","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535244710?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:04","pubTimestamp":1747227867,"startTime":"0","endTime":"0","summary":"MetaVia Inc., a clinical-stage biotechnology company focused on cardiometabolic diseases, has announced a $10.0 million private placement priced at-the-market under Nasdaq rules. The offering includes the purchase of 9,479,345 shares of common stock at $0.71 per share, along with 4,605,162 pre-funded warrants priced at $0.709 each. The pre-funded warrants come with an exercise price of $0.001 per warrant and are contingent on receiving stockholder approval for the underlying shares. Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for this offering. MetaVia plans to use the net proceeds for working capital and corporate purposes, including the clinical development of DA-1726 for obesity treatment. The closing of the private placement is anticipated on or about May 12, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL4sfZnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2534485955","title":"BRIEF-Metavia Announces $10 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2534485955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534485955?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:02","pubTimestamp":1746792135,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Announces $10 Million Private Placement Priced At-The-Market Under Nasdaq RulesMay 9 (Reuters) - MetaVia Inc MTVA.O:METAVIA ANNOUNCES $10.0 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUAC4LR7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2534485667","title":"Metavia Announces $10.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2534485667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534485667?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:01","pubTimestamp":1746792062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUAC4LR7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2534485628","title":"Metavia Inc - Proceeds to Fund Da-1726 Clinical Development for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2534485628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534485628?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:01","pubTimestamp":1746792062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUAC4LR7X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2534048564","title":"Metavia Inc - Offering Includes Purchase of 9,479,345 Shares at $0.71 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2534048564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534048564?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:01","pubTimestamp":1746792062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUAC4LR7X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2533603369","title":"MetaVia announces data from DA-1241 trial at EASL","url":"https://stock-news.laohu8.com/highlight/detail?id=2533603369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533603369?lang=en_us&edition=fundamental","pubTime":"2025-05-07 17:42","pubTimestamp":1746610941,"startTime":"0","endTime":"0","summary":"MetaVia (MTVA) announced that data from its Phase 2a clinical trial of DA-1241, a novel G-Protein-Coupled Receptor 119 agonist, in patients with pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-announces-data-from-da-1241-trial-at-easl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-announces-data-from-da-1241-trial-at-easl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2533538347","title":"MetaVia Inc  expected to post a loss of 60 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533538347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533538347?lang=en_us&edition=fundamental","pubTime":"2025-05-05 22:11","pubTimestamp":1746454269,"startTime":"0","endTime":"0","summary":"MetaVia Inc  expected to post a loss of60cents a share - Earnings Preview MetaVia Inc MTVA.OQ MTVA.O is expected to show no change in quarterly revenue when it reports  results on May 7 (estimated) fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD1IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"MTVA","fiscalQuarterEnding":"2025/03","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.36},{"date":"2025-03-20","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742457600000,"name":null,"time":"Pre-Market","dateTimestamp":1742443200000,"actualEps":null},{"market":"US","date":"2024-11-07","symbol":"MTVA","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-08-14","symbol":"MTVA","fiscalQuarterEnding":"2024/06","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-1.85},{"market":"US","date":"2024-05-09","symbol":"MTVA","fiscalQuarterEnding":"2024/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2025-06-10","current":-0.573323,"percent":0.294574,"low":-0.807761,"twenty":-0.608927,"median":-0.498502,"eighty":-0.284117,"high":-0.203888,"avg":-0.490999,"sd":0.1544,"marketCap":14074495},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270},{"date":"2025-04-25","current":-0.266622,"twenty":-0.631917,"median":-0.512617,"eighty":-0.463425,"marketCap":7356638},{"date":"2025-05-02","current":-0.239019,"twenty":-0.626947,"median":-0.506404,"eighty":-0.454331,"marketCap":6595010},{"date":"2025-05-09","current":-0.222708,"twenty":-0.618869,"median":-0.49874,"eighty":-0.452346,"marketCap":6144956},{"date":"2025-05-16","current":-0.238257,"twenty":-0.615141,"median":-0.497083,"eighty":-0.429105,"marketCap":5848960},{"date":"2025-05-23","current":-0.285534,"twenty":-0.611413,"median":-0.49458,"eighty":-0.263184,"marketCap":7009578},{"date":"2025-05-30","current":-0.543676,"twenty":-0.612655,"median":-0.49689,"eighty":-0.271352,"marketCap":13346706},{"date":"2025-06-06","current":-0.549972,"twenty":-0.608927,"median":-0.497673,"eighty":-0.281282,"marketCap":13501264},{"date":"2025-06-10","current":-0.573323,"twenty":-0.608927,"median":-0.498502,"eighty":-0.284117,"marketCap":14074495}],"updateTime":1749662325015}}}